Allergic & Irritant Contact Dermatitis Treatment
Covered by Aetna in California

Triamcinolone acetonide 0.1% cream twice daily × 7–14 days for mild-to-moderate allergic or irritant contact dermatitis on body (not face); desonide 0.05% cream twice daily for facial or intertriginous involvement (lower potency appropriate for thin-skinned areas); oral cetirizine 10 mg daily or hydroxyzine 25 mg at bedtime for pruritus control

Clobetasol propionate 0.05% cream once daily × 7–14 days for severe or thick-skinned involvement (palms, soles, dorsal hands) — high-potency steroid, limit to 2-week courses; mometasone furoate 0.1% cream once daily as a mid-potency alternative; for widespread or severe acute allergic contact dermatitis (e.g., poison oak, latex) — oral prednisone 40–60 mg daily with 14–21 day taper is often necessary to prevent rebound; tacrolimus 0.1% ointment for recurrent facial contact dermatitis when repeated steroid courses raise skin atrophy concern

Yes — generic triamcinolone, desonide, and clobetasol are Tier 1 formulary generics on Aetna CA; triamcinolone 0.1% cream typically $4–$15 for 30g. Oral prednisone generic is $4–$10. Hydroxyzine generic is $4–$15. Branded topical steroids (e.g., Kenalog cream branded) require step therapy through generic equivalent first.

Irritant contact dermatitis (ICD) accounts for approximately 80% of all contact dermatitis — caused by repeated exposure to soaps, detergents, or chemical irritants without requiring prior sensitization. Allergic contact dermatitis (ACD) requires sensitization and typically presents 24–72 hours after re-exposure. Poison oak (Toxicodendron diversilobum), the most potent contact allergen in California, causes ACD and frequently requires systemic steroids. The cornerstone of treatment for both types is allergen/irritant avoidance; topical or systemic steroids manage acute inflammation. Patch testing (North American Contact Dermatitis Group standard series) is definitive for ACD and is covered by Aetna CA but requires in-person dermatology.

Yes — poison oak (Toxicodendron diversilobum) ACD is one of the most telehealth-appropriate dermatology presentations. The clinical picture (linear streaks of vesicles and erythema, history of brush contact, delay of 12–72 hours between exposure and rash) is visually distinctive via video. For moderate-to-severe poison oak reactions, Dr. Bhavsar will prescribe an oral prednisone taper (typically 40–60 mg/day tapering over 14–21 days) — short courses are essential because premature discontinuation leads to rebound. Generic oral prednisone is $4–$10 at California pharmacies and is covered by Aetna CA. A full 14–21 day taper is necessary because urushiol (the allergen) remains active in skin for 2–3 weeks.

Yes — patch testing (CPT 95044) is a covered medical benefit under Aetna CA for contact allergic dermatitis (ICD-10 L23.x). However, patch testing requires an in-person visit with a dermatologist or allergist who applies a standard series (or extended series) of allergen panels to the back, evaluates readings at 48 and 96 hours, and interprets clinical relevance. TDMD's telehealth visit can initiate treatment for your current flare, but if recurrent or occupational contact dermatitis is suspected, Dr. Bhavsar will coordinate a referral for formal patch testing.

Yes, with quantity limits. Aetna CA's topical corticosteroid policy allows up to 180 g of generic topical steroids per month without prior authorization. Repeated short courses for recurrent ACD are covered. However, if you're using topical steroids on the face repeatedly or needing continuous steroid therapy to control symptoms, this suggests inadequate allergen avoidance and Dr. Bhavsar will discuss referral for patch testing. Chronic facial steroid use can cause skin atrophy and — paradoxically — perioral dermatitis or steroid rosacea.

Yes. Aetna commercial plans cover telehealth visits for Allergic & Irritant Contact Dermatitis in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your contact dermatitis treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your contact dermatitis treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.